Completed
This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population
NCT01158599
- Conditions
- Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- Institut für Spezifische Prophylaxe und Tropenmedizin Vienna, State of Vienna, Austria
- Medical University of Vienna - Klinische Pharmakologie Vienna, State of Vienna, Austria
- Universitätsklinikum Hamburg-Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany
- Universitätsklinikum Rostock Rostock, Germany